TABLE 5.
Adverse Events and Adverse Drug Reactions
| pH-2.4 g (n = 65) |
Time-2.25 g (n = 65) |
|||
|---|---|---|---|---|
| No. of Patients | (%) | No. of Patients | (%) | |
| Adverse events* | 62 | (95.4) | 62 | (95.4) |
| Nasopharyngitis | 32 | (49.2) | 31 | (47.7) |
| Diarrhea | 4 | (6.2) | 9 | (13.8) |
| C-reactive protein increased | 19 | (29.2) | 18 | (27.7) |
| Beta-N-acetyl-D-glucosaminidase increased | 13 | (20.0) | 18 | (27.7) |
| Eosinophil count increased | 11 | (16.9) | 14 | (21.5) |
| Blood bilirubin increased | 10 | (15.4) | 8 | (12.3) |
| Bilirubin conjugated increased | 9 | (13.8) | 5 | (7.7) |
| Alanine aminotransferase increased | 7 | (10.8) | 6 | (9.2) |
| Monocyte count increased | 6 | (9.2) | 10 | (15.4) |
| Adverse drug reactions | 29 | (44.6) | 31 | (47.7) |
Events that occurred in more than 10% of the patients in at least one group.